Fractalkine is an independent predictor of mortality in patients with advanced heart failure.
Richter B, Koller L, Hohensinner PJ, Rychli K, Zorn G, Goliasch G, Berger R, Mörtl D, Maurer G, Huber K, Pacher R, Wojta J, Hülsmann M, Niessner A.
Richter B, et al. Among authors: niessner a.
Thromb Haemost. 2012 Dec;108(6):1220-7. doi: 10.1160/TH12-03-0195. Epub 2012 Sep 26.
Thromb Haemost. 2012.
PMID: 23014777
Clinical Trial.